Cargando…
Generation of novel trimeric fragments of human SP-A and SP-D after recombinant soluble expression in E. coli
Surfactant treatment for neonatal respiratory distress syndrome has dramatically improved survival of preterm infants. However, this has resulted in a markedly increased incidence of sequelae such as neonatal chronic inflammatory lung disease. The current surfactant preparations in clinical use lack...
Autores principales: | Watson, Alastair, Sørensen, Grith L., Holmskov, Uffe, Whitwell, Harry J., Madsen, Jens, Clark, Howard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422833/ https://www.ncbi.nlm.nih.gov/pubmed/32747028 http://dx.doi.org/10.1016/j.imbio.2020.151953 |
Ejemplares similares
-
Novel expression of a functional trimeric fragment of human SP-A with efficacy in neutralisation of RSV
por: Watson, Alastair, et al.
Publicado: (2017) -
SP-A and SP-D: Dual Functioning Immune Molecules With Antiviral and Immunomodulatory Properties
por: Watson, Alastair, et al.
Publicado: (2021) -
Reduced influenza viral neutralizing activity of natural human trimers of surfactant protein D
por: Hartshorn, Kevan L, et al.
Publicado: (2007) -
Cooperative action of SP-A and its trimeric recombinant fragment with polymyxins against Gram-negative respiratory bacteria
por: Coya, Juan Manuel, et al.
Publicado: (2022) -
A Variant Form of the Human Deleted in Malignant Brain Tumor 1 (DMBT1) Gene Shows Increased Expression in Inflammatory Bowel Diseases and Interacts with Dimeric Trefoil Factor 3 (TFF3)
por: Madsen, Jens, et al.
Publicado: (2013)